Indoleamine 2,3-dioxygenase 1 inhibitors: Molecular pharmacology, structural biology and medicinal chemistry with therapeutic perspectives for Huntington's disease
Biological Psychology
· Elsevier
Abstract
Publication date: 1 January 2027 Source: Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Volume 1875, Issue 1 Author(s): Vishnu Malakar, Chandi C. Malakar, Pratap Chand Mali, Nitesh Kumar Poddar
Read at publisher →
Citation
Indoleamine 2,3-dioxygenase 1 inhibitors: Molecular pharmacology, structural biology and medicinal chemistry with therapeutic perspectives for Huntington's disease. // Biological Psychology. – URL: https://www.sciencedirect.com/science/article/pii/S1570963926000543?dgcid=rss_sd_all
Indoleamine 2,3-dioxygenase 1 inhibitors: Molecular pharmacology, structural biology and medicinal chemistry with therapeutic perspectives for Huntington's disease. Biological Psychology. https://www.sciencedirect.com/science/article/pii/S1570963926000543?dgcid=rss_sd_all
“Indoleamine 2,3-dioxygenase 1 inhibitors: Molecular pharmacology, structural biology and medicinal chemistry with therapeutic perspectives for Huntington's disease.” Biological Psychology.
@article{article4162,
title = {Indoleamine 2,3-dioxygenase 1 inhibitors: Molecular pharmacology, structural biology and medicinal chemistry with therapeutic perspectives for Huntington's disease},
journal = {Biological Psychology},
url = {https://www.sciencedirect.com/science/article/pii/S1570963926000543?dgcid=rss_sd_all}
}